Skip NavigationSkip to Content

S-acylation of SARS-CoV-2 Spike Protein: Mechanistic Dissection, In Vitro Reconstitution and Role in Viral Infectivity

  1. Author:
    Puthenveetil, Robbins
    Lun, Cheng Man
    Murphy, R Elliot
    Healy, Liam B
    Vilmen,Geraldine
    Christenson, Eric T
    Freed,Eric
    Banerjee, Anirban
  2. Author Address

    Section on Structural and Chemical Biology of Membrane Proteins, Neurosciences and Cellular and Structural Biology Division, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA., Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA., Section on Structural and Chemical Biology of Membrane Proteins, Neurosciences and Cellular and Structural Biology Division, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: anirban.banerjee@nih.gov.,
    1. Year: 2021
    2. Date: Oct
    3. Epub Date: 2021 08 21
  1. Journal: The Journal of biological chemistry
    1. 297
    2. 4
    3. Pages: 101112
  2. Type of Article: Article
  3. Article Number: 101112
  4. ISSN: 1083-351X
  1. Abstract:

    S-acylation, also known as palmitoylation, is the most widely prevalent form of protein lipidation, whereby long chain fatty acids get attached to cytosol-facing cysteines. In humans, 23 members of the zDHHC family of integral membrane enzymes catalyze this modification. S-acylation is critical for the life cycle of many enveloped viruses. The Spike protein of SARS-CoV-2, the causative agent of COVID-19, has the most cysteine-rich cytoplasmic tail among known human pathogens in the closely-related family of ß-coronaviruses; however, it is unclear which of the cytoplasmic cysteines are S-acylated or the impact of this modification on viral infectivity. Here we identify specific cysteine clusters in the Spike protein of SARS-CoV-2 that are targets of S-acylation. Interestingly, when we investigated the effect of the cysteine clusters using pseudotyped virus, mutation of the same three clusters of cysteines severely compromises viral infectivity. We developed a library of expression constructs of human zDHHC enzymes and used them to identify zDHHC enzymes that can S-acylate the SARS-CoV-2 Spike protein. Finally, we reconstituted S-acylation of SARS-CoV-2 Spike protein in vitro using purified zDHHC enzymes. We observe a striking heterogeneity in the S-acylation status of the different cysteines in our in cellulo experiments which, remarkably, was recapitulated by the in vitro assay. Altogether, these results bolster our understanding of a poorly understood posttranslational modification integral to the SARS-CoV-2 Spike protein. This study opens up avenues for further mechanistic dissection and lays the groundwork towards developing future strategies that could aid in the identification of targeted small-molecule modulators. Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.jbc.2021.101112
  2. PMID: 34428449
  3. WOS: 000713004000007
  4. PII : S0021-9258(21)00915-7

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel